Healthcare -
Biotechnology - NASDAQ - US
$ 6.29
-4.26 %
$ 312 M
Market Cap
-1.26
P/E
RGNX - OPERATING EXPENSES
Operating Expenses RGNX - REGENXBIO Inc.
321 M
LAST VALUE
11.46%
2 YEAR CAGR
21.61%
5 YEAR CAGR
40.75%
10 YEAR CAGR